Global Blood Coagulants Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Blood Coagulants Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Coagulation is the process, by which blood changes from a liquid to a gel, forming a blood clot. In general terms, coagulation is a process in which the blood forms clots to block and then heal a lesion/wound/cut and stop the bleeding.
Blood Coagulants report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Blood Coagulants market is projected to reach US$ 628.6 million in 2034, increasing from US$ 391.9 million in 2022, with the CAGR of 6.5% during the period of 2024 to 2034. Demand from Hospital and Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Blood Coagulants industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Blood Coagulants key manufacturers include Pfizer, Bayer, Novo Nordisk, Takeda, SOBI, Octapharma and CSL, etc. Pfizer, Bayer, Novo Nordisk are top 3 players and held % sales share in total in 2022.
Blood Coagulants can be divided into Recombinant Coagulation Factor and Plasma Coagulation Factor, etc. Recombinant Coagulation Factor is the mainstream product in the market, accounting for % sales share globally in 2022.
Blood Coagulants is widely used in various fields, such as Hospital, Pharmacy and Other,, etc. Hospital provides greatest supports to the Blood Coagulants industry development. In 2022, global % sales of Blood Coagulants went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Blood Coagulants market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Sale Channel and Regions Listed in the Report
Pfizer
Bayer
Novo Nordisk
Takeda
SOBI
Octapharma
CSL
Segment by Type
Recombinant Coagulation Factor
Plasma Coagulation Factor
Segment by Sale Channel
Hospital
Pharmacy
Other
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Blood Coagulants market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Blood Coagulants, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Blood Coagulants industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Blood Coagulants in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Sale Channel, Volume and Revenue analysis of Each Sale Channel in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Blood Coagulants introduction, etc. Blood Coagulants Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Blood Coagulants market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Blood Coagulants report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Blood Coagulants market is projected to reach US$ 628.6 million in 2034, increasing from US$ 391.9 million in 2022, with the CAGR of 6.5% during the period of 2024 to 2034. Demand from Hospital and Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Blood Coagulants industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Blood Coagulants key manufacturers include Pfizer, Bayer, Novo Nordisk, Takeda, SOBI, Octapharma and CSL, etc. Pfizer, Bayer, Novo Nordisk are top 3 players and held % sales share in total in 2022.
Blood Coagulants can be divided into Recombinant Coagulation Factor and Plasma Coagulation Factor, etc. Recombinant Coagulation Factor is the mainstream product in the market, accounting for % sales share globally in 2022.
Blood Coagulants is widely used in various fields, such as Hospital, Pharmacy and Other,, etc. Hospital provides greatest supports to the Blood Coagulants industry development. In 2022, global % sales of Blood Coagulants went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Blood Coagulants market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Sale Channel and Regions Listed in the Report
By Company
Pfizer
Bayer
Novo Nordisk
Takeda
SOBI
Octapharma
CSL
Segment by Type
Recombinant Coagulation Factor
Plasma Coagulation Factor
Segment by Sale Channel
Hospital
Pharmacy
Other
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Blood Coagulants market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Blood Coagulants, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Blood Coagulants industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Blood Coagulants in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Sale Channel, Volume and Revenue analysis of Each Sale Channel in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Blood Coagulants introduction, etc. Blood Coagulants Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Blood Coagulants market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices